Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $55,929 | 14 | 61.6% |
| Travel and Lodging | $25,174 | 20 | 27.7% |
| Unspecified | $3,900 | 3 | 4.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,905 | 1 | 3.2% |
| Food and Beverage | $1,635 | 19 | 1.8% |
| Education | $1,267 | 1 | 1.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $45,654 | 24 | $0 (2019) |
| Eisai Inc. | $40,849 | 28 | $0 (2024) |
| Eli Lilly and Company | $3,900 | 3 | $0 (2022) |
| Biogen, Inc. | $405.54 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,536 | 14 | Eisai Inc. ($7,470) |
| 2023 | $10,509 | 8 | Eisai Inc. ($10,443) |
| 2022 | $13,497 | 5 | EISAI INC. ($12,837) |
| 2021 | $3,218 | 1 | Eisai Inc. ($3,218) |
| 2020 | $270.00 | 1 | Eli Lilly and Company ($270.00) |
| 2019 | $25,907 | 11 | F. Hoffmann-La Roche AG ($19,026) |
| 2018 | $26,629 | 16 | F. Hoffmann-La Roche AG ($26,629) |
| 2017 | $3,244 | 2 | Eli Lilly and Company ($2,970) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $3,180.00 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $152.19 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $24.11 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $17.47 | General |
| Category: Neurology | ||||||
| 11/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $51.94 | General |
| Category: Neurology | ||||||
| 11/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $37.71 | General |
| Category: Neurology | ||||||
| 11/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Neurology | ||||||
| 11/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $65.99 | General |
| 10/02/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $3,710.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.78 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $68.34 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $52.19 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Neurology | ||||||
| 12/20/2023 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $1,237.50 | General |
| Category: Neurology | ||||||
| 10/25/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $39.48 | General |
| Category: Neurology | ||||||
| 08/23/2023 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $5,300.00 | General |
| Category: Neurology | ||||||
| 08/23/2023 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $339.14 | General |
| Category: Neurology | ||||||
| 07/20/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $44.95 | General |
| Category: Neurology | ||||||
| 07/20/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: Neurology | ||||||
| 07/18/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $66.05 | General |
| 04/26/2023 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $3,465.00 | General |
| Category: Neurology | ||||||
| 12/21/2022 | EISAI INC. | — | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 12/21/2022 | EISAI INC. | — | Travel and Lodging | Cash or cash equivalent | $338.53 | General |
| 12/19/2022 | EISAI INC. | — | Consulting Fee | Cash or cash equivalent | $8,415.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND DELAYED-START STUDY OF LY3314814 IN MILD ALZHEIMERS DISEASE DEMENTIA | Eli Lilly and Company | $2,970 | 1 |
| ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY | Eli Lilly and Company | $930.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 19 | $9,405 | $1,957 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 19 | $9,405 | $1,957 | 20.8% |
About Dr. Christopher Vandyck, MD
Dr. Christopher Vandyck, MD is a Psychiatry healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821088188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Vandyck, MD has received a total of $90,809 in payments from pharmaceutical and medical device companies, with $7,536 received in 2024. These payments were reported across 58 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($55,929).
As a Medicare-enrolled provider, Vandyck has provided services to 13 Medicare beneficiaries, totaling 19 services with total Medicare billing of $1,957. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location New Haven, CT
- Active Since 10/26/2005
- Last Updated 04/07/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1821088188
Products in Payments
- Non-Covered Product (Drug) $42,034
- Leqembi (Drug) $17,913
- None (Drug) $3,218
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in New Haven
Dr. Vladimir Coric, M.d, M.D
Psychiatry — Payments: $133.7M
Robert Berman, Md, MD
Psychiatry — Payments: $126,072
Dr. Gerard Sanacora, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $119,486
Thomas Stewart, Md, MD
Psychiatry — Payments: $107,721
Scott Woods, Md, MD
Psychiatry — Payments: $64,549
Paula Zimbrean, Md, MD
Psychiatry — Payments: $54,086